Pharmaceutical Business review

Calypte wins Chinese approval for oral HIV test

This approval makes the Aware HIV-1/2 OMT test the first and only State Food and Drug Administration approved rapid oral fluid HIV test in China.

David Harris, Beijing Marr’s CEO, said: “We now plan to ramp up our production capacity as we build our distribution network to fully realize the market potential of the Aware HIV-1/2 OMT test in China.”